S.2296 National Defense Authorization Act
Literal federal measure citations: S.2296
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- Not reported
- Expenses
- $490,000.00
- Registrant
- VIATRIS INC.
- Client
- VIATRIS INC
- Filing UUID
- 55c3af8b-d4ed-40ca-a3f6-5f5e8cd2d40a
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Literal federal measure citations: HR 9747
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Literal federal measure citations: S. 891, H.R. 1843, S. 1302, HR 4132, S.2027, S.2658
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Literal federal measure citations: S 1553
Trade issues related to generic medicines Pharmaceutical supply chain
Policy related to corporate governance
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.